MENU
+Compare
BDRX
Stock ticker: NASDAQ
AS OF
Mar 3, 04:50 PM (EDT)
Price
$2.92
Change
-$0.42 (-12.61%)
Capitalization
2.23M

BDRX Biodexa Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines... Show more

Industry: #Biotechnology
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BDRX with price predictions
Feb 28, 2025

BDRX's Stochastic Oscillator is staying in oversold zone for 15 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BDRX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BDRX as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BDRX turned negative on February 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

BDRX moved below its 50-day moving average on February 14, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BDRX crossed bearishly below the 50-day moving average on February 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BDRX broke above its upper Bollinger Band on February 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.201) is normal, around the industry mean (11.857). P/E Ratio (0.000) is within average values for comparable stocks, (80.120). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.578). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (13.587) is also within normal values, averaging (242.214).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BDRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company which designs and manufactures nanomedicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Caspian Point
Phone
+44 2920480180
Employees
27
Web
https://www.biodexapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WRAP2.190.13
+6.31%
Wrap Technologies
CLBT18.560.06
+0.32%
Cellebrite DI Ltd
BIO265.16-0.47
-0.18%
Bio-Rad Laboratories IncClass A
GPRK8.10-0.24
-2.88%
Geopark Limited
DUO0.50-0.02
-3.15%
Fangdd Network Group Ltd

BDRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-3.48%
LVTX - BDRX
41%
Loosely correlated
N/A
ATNF - BDRX
38%
Loosely correlated
N/A
AVTX - BDRX
33%
Loosely correlated
+10.76%
SCNI - BDRX
32%
Poorly correlated
+0.10%
ATXI - BDRX
31%
Poorly correlated
-12.00%
More